Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jul 11;8(28):45040-45041.
doi: 10.18632/oncotarget.18364.

Epigenetic control of epileptogenesis by miR-146a

Affiliations
Editorial

Epigenetic control of epileptogenesis by miR-146a

Valentina Iori et al. Oncotarget. .
No abstract available

Keywords: disease-modification; epilepsy; microRNA; neuroinflammation; seizures.

PubMed Disclaimer

Figures

Figure 1
Figure 1. IL-1R1/TLR4 signaling inhibition by miR-146a mimic in neurons and astrocytes
The activation of IL-1R1/TLR4 axis promotes seizure generation in susceptible brain areas by a twofold mechanism mediated by IL-1β and HMGB1 activation of neuronal or astrocyte receptors. A. Activation of IL-1R1/TLR4 axis in neurons provokes hyper-excitability by enhancing Ca2+ influx via the glutamate-sensitive N-methyl-D-aspartate receptor (NMDAR). This fast-onset posttranslational response involves ceramide-induced Src kinase phosphorylation (P) of the NR2B subunit of the NMDAR which regulates Ca2+ influx [5]. B. Activation of IL-1R1/TLR4 axis in astrocytes induces NF-κB- and AP-1 dependent transcription of inflammatory genes. miR-146a mimic (red cross) down-regulates IRAK1/2 and TRAF6 intracellular proteins (downward arrow) which are required for IL-1R1/TLR4 signal transduction. IL-1R1/TLR4 axis inhibition by miR-146a mimic -or using a combination of drugs, namely VX-765 that blocks IL-1β biosynthesis, and Cyanobacterial LPS, a TLR4 antagonist [6]- reduces hyper-excitability and neuroinflammation (downward arrow) in mice developing epilepsy, thus resulting in therapeutic outcomes.

References

    1. Duncan JS, et al. Lancet. 2006;367:1087–100. - PubMed
    1. Henshall DC, et al. Cold Spring Harb Perspect Med. 2015:5. - PMC - PubMed
    1. Cattani AA, et al. Epilepsia. 2016;57:1015–26. - PubMed
    1. Vezzani A, et al. Cold Spring Harb Perspect Med. 2015;6:a022699. - PMC - PubMed
    1. Vezzani A, et al. Neuropharmacology. 2015;96:70–82. - PubMed

Publication types

LinkOut - more resources